I have spent 15 years leading manufacturing operations with full P&L responsibility, building a career on the principle that sustainable results require optimizing operations, strategy, and culture in equal measure.
My track record includes leading the turnaround of a $6MM distressed injection molder into a $25MM strategic manufacturing partner, delivering 4x revenue growth and a 5x increase in enterprise value.
I started my career conducting pre- and post-transaction due diligence for PE firms and corporate clients. I moved into financial advisory, where I sourced and structured M&A transactions, including the acquisition of a distressed manufacturing company.
That transaction became the foundation of my operating career. I transitioned from advisor to operator, taking on the Director of Operations role to execute the turnaround of a business running over budget with 50% RMA rates and deteriorating stakeholder confidence.
Over the next 13 years, I led the transformation of that asset from a distressed commodity supplier to a profitable precision manufacturing partner serving Fortune 500 customers.
Served as Acting CEO with full P&L authority. Led enterprise strategy for a $25MM manufacturer serving Fortune 500 medical, energy, and industrial customers. Delivered 67% revenue growth ($15MM to $25MM) during tenure, while overseeing a 120-person operation and a seven-member executive team.
Built a $200MM+ multi-year contract pipeline and reduced customer concentration risk from 60% to 35% through deliberate account diversification.
Directed the transformation to an automated precision operation serving the regulated medical device market. Maintained gross margins during a $2.5MM equipment investment cycle ("lights-out" automation) while delivering double-digit revenue growth.
Championed ISO 9001:2015 certification, which unlocked access to regulated markets and supported customer partnerships representing 60% of subsequent growth.
Led operational transformation following acquisition. Restored profitability and customer confidence within 24 months despite inheriting a 50% RMA rate. Reduced RMA to industry standards within 18 months through root cause analysis and process controls.
Made the critical strategic call to exit unprofitable commodity work and reposition the sales strategy to target higher-margin regulated industrial OEMs.
Sourced and structured the M&A transaction, including SBA financing and due diligence. Joined post-acquisition to stabilize Fortune 500 relationships, achieving 100% customer retention while identifying the operational inefficiencies blocking growth.
Provided strategic financial advisory services, conducting pre-transaction due diligence and investment analysis for institutional and private clients. Sourced and structured middle-market M&A transactions, identifying the distressed asset opportunity that launched the subsequent operating turnaround.
Governance oversight including strategic planning, capital allocation, and M&A transactions.
Development committee leadership and fundraising for regional performing arts organization.
2024 Honoree
2021 Honoree
B.S. Economics
Texas Christian University | Fort Worth, TX
Available for select opportunities with PE-backed manufacturing operations.
Connect via Email